Sun Pharma to sell some Merck diabetes drugs in India

Sun Pharmaceutical Industries Ltd has entered into a deal to market Merck's diabetes drugs - sitagliptin and sitagliptin plus metformin in India, the two drugmakers said in a statement on Monday.

April 29, 2011 / 15:27 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Sun Pharmaceutical Industries Ltd has entered into a deal to market Merck's diabetes drugs - sitagliptin and sitagliptin plus metformin in India, the two drugmakers said in a statement on Monday.

Under the deal, Sun will have the rights to market the drugs only in India under different brand names, the firms said.

Earlier in April, Sun and Merck formed a joint venture to develop and manufacture generic drugs for emerging markets.

first published: Apr 25, 2011 11:29 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347